Task: Answer the multiple-choice question.
Query: Which drug exhibits a 9.453% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a CC1CCc2c(sc(NC(=O)C3CCCO3)c2C#N)C1
b O=C(Cc1sc(-c2ccccc2)nc1-c1ccccc1)Nc1ccccc1
c CC(=NCC1CCNCC1)C1=C(O)CC(C)(C)CC1=O
Answer: a. CC1CCc2c(sc(NC(=O)C3CCCO3)c2C#N)C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CCc2c(sc(NC(=O)C3CCCO3)c2C#N)C1
CC1CCc2c(sc(NC(=O)C3CCCO3)c2C#N)C1
N-(3-cyano-6-methyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)oxolane-2-carboxamide